Claw lesions diagnosed | MS 1 (%) | MS 2 (%) | MS 3 (%) | Total (%) |
---|---|---|---|---|
Infectious lesion Digital dermatitis | 0 | 0 | 3.3 | 3.3 |
Heel erosion | 2.2 | 2.2 | 0 | 4.4 |
Interdigital dermatitis | 1.1 | 0 | 3.3 | 4.4 |
Non-infectious lesion | ||||
Abscess | 4.4 | 1.1 | 6.7 | 12.2 |
Double sole | 4.4 | 2.2 | 1.1 | 7.8 |
Heel inflammation | 3.3 | 0 | 1.1 | 4.4 |
Interdigital callus | 0 | 0 | 2.2 | 2.2 |
Overgrowth | 1.1 | 1.1 | 0 | 2.2 |
Sole haemorrhage | 4.4 | 12.2 | 2.2 | 18.9 |
Ulcer | 2.2 | 3.3 | 7.8 | 13.3 |
White line disease | 10 | 11.1 | 5.6 | 26.7 |
Variable | Estimated | Std. Error | 95% CI |
---|---|---|---|
Norepinephrine | |||
MS0 | 655.83 | 24.09 | 607.83 – 703.83 |
MS1 | −4.86 | 35.54 | −75.67 – 65.94 |
MS2 | 65.85 | 34.07 | −2.03 – 133.72 |
MS3 | 245.45 | 33.66 | 178.39 – 312.51 |
β-endorphin | |||
MS0 | 46.6 | 1.49 | 43.61 – 49.57 |
MS1 | −3.8 | 2.2 | −8.20 – 0.59 |
MS2 | −5.75 | 2.11 | −9.96 – −1.54 |
MS3 | −7.84 | 2.09 | −11.0 – −3.68 |
Substance P | |||
MS0 | 0.25 | 0.09 | 0.08 – 0.43 |
MS1 | 0.07 | 0.13 | −0.19 – 0.33 |
MS2 | 0.17 | 0.12 | −0.08 – 0.41 |
MS3 | 0.61 | 0.12 | 0.37 – 0.86 |